For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term. Is This 1 Momentum Stock a Screaming Buy Right Now? Different than value or growth investors, momentum-oriented investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks. HashiCorp, Inc. (HCP) Headquartered in Irvine, CA, HCP, Inc. is a real estate investment trust (REIT) in the United States that acquires, develops, manages, sells and leases a diverse portfolio of healthcare real estate related properties. The company divides its operations into following four reportable segments: senior housing triple-net, senior housing operating portfolio (SHOP), life science and medical office. As of June 30, 2019, HCP’s portfolio of investments, including properties in its unconsolidated joint ventures (JV), comprised interests in 745 properties. HCP sits at a Zacks Rank #2 (Buy), holds a Momentum Style Score of B, and has a VGM Score of B. The stock is down 0.1% and up 1.9% over the past one-week and four-week period, respectively, and HashiCorp, Inc. has gained 49.7% in the last one-year period as well. Additionally, an average of 2,331,919 shares were traded over the last 20 trading sessions. A company's earnings performance is important for momentum investors as well. For fiscal 2025, three analysts revised their earnings estimate higher in the last 60 days for HCP, while the Zacks Consensus Estimate has increased $0.07 to $0.34 per share. HCP also boasts an average earnings surprise of 386.7%. With strong earnings growth, a good Zacks Rank, and top-tier Momentum and VGM Style Scores, investors should think about adding HCP to their portfolios. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report HashiCorp, Inc. (HCP):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments
Why HashiCorp, Inc. (HCP) is a Top Momentum Stock for the Long-Term
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...